Risk factors for ductal and lobular breast cancer: Results from the nurses' health study

Breast Cancer Research

Volumn 12, Issue 6, 2010, Pages

  Kotsopoulos, Joanne ^a   Chen, Wendy Y ^a,b   Gates, Margaret A ^a,c   Tworoger, Shelley S ^a,c   Hankinson, Susan E ^a,c   Rosner, Bernard A ^a,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; BREAST CARCINOMA; CANCER RISK; FEMALE; HISTOPATHOLOGY; HUMAN; INTRADUCTAL CARCINOMA; LOBULAR BREAST CARCINOMA; MAJOR CLINICAL STUDY; MENARCHE; MENOPAUSE; NULLIPARA; PARITY; POSTMENOPAUSE; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK FACTOR; AGE; BREAST TUMOR; DRINKING BEHAVIOR; ESTROGEN THERAPY; FAMILY HEALTH; LUNG CARCINOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; PAGET NIPPLE DISEASE;

ADULT; AGE FACTORS; ALCOHOL DRINKING; BODY MASS INDEX; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; ESTROGEN REPLACEMENT THERAPY; FAMILY HEALTH; FEMALE; HUMANS; MENOPAUSE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS;

EID: 78649766452     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr2790     Document Type: Article

References (47)

1. Kelsey JL, Gammon MD, John EM. Reproductive factors and breast cancer. Epidemiol Rev 1993, 15:36-47.
2. Bernstein L. Epidemiology of endocrine-related risk factors for breast cancer. J Mammary Gland Biol Neoplasia 2002, 7:3-15. 10.1023/A:1015714305420, 12160084.
3. Li CI, Anderson BO, Daling JR, Moe RE. Trends in incidence rates of invasive lobular and ductal breast carcinoma. JAMA 2003, 289:1421-1424. 10.1001/jama.289.11.1421, 12636465.
4. Cocquyt V, Van Belle S. Lobular carcinoma in situ and invasive lobular cancer of the breast. Curr Opin Obstet Gynecol 2005, 17:55-60.
5. Arpino G, Bardou VJ, Clark GM, Elledge RM. Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome. Breast Cancer Res 2004, 6:R149-R156. 10.1186/bcr767, 400666, 15084238.
6. Korhonen T, Huhtala H, Holli K. A comparison of the biological and clinical features of invasive lobular and ductal carcinomas of the breast. Breast Cancer Res Treat 2004, 85:23-29. 10.1023/B:BREA.0000021038.97593.8b, 15039595.
7. Calle EE, Feigelson HS, Hildebrand JS, Teras LR, Thun MJ, Rodriguez C. Postmenopausal hormone use and breast cancer associations differ by hormone regimen and histologic subtype. Cancer 2009, 115:936-945. 10.1002/cncr.24101, 19156895.
8. Rosenberg LU, Einarsdottir K, Friman EI, Wedren S, Dickman PW, Hall P, Magnusson C. Risk factors for hormone receptor-defined breast cancer in postmenopausal women. Cancer Epidemiol Biomarkers Prev 2006, 15:2482-2488. 10.1158/1055-9965.EPI-06-0489, 17164374.
9. Stalsberg H, Thomas DB, Noonan EA. Histologic types of breast carcinoma in relation to international variation and breast cancer risk factors. WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Int J Cancer 1989, 44:399-409. 10.1002/ijc.2910440304, 2777405.
10. Daling JR, Malone KE, Doody DR, Voigt LF, Bernstein L, Coates RJ, Marchbanks PA, Norman SA, Weiss LK, Ursin G, Berlin JA, Burkman RT, Deapen D, Folger SG, McDonald JA, Simon MS, Strom BL, Wingo PA, Spirtas R. Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinoma. Cancer 2002, 95:2455-2464. 10.1002/cncr.10984, 12467057.
11. Colditz GA. The Nurses' Health Study: a cohort of US women followed since 1976. J Am Med Womens Assoc 1995, 50:40-44.
12. Colditz GA, Manson JE, Hankinson SE. The Nurses' Health Study: 20-year contribution to the understanding of health among women. J Womens Health 1997, 6:49-62. 10.1089/jwh.1997.6.49, 9065374.
13. Colditz GA, Hankinson SE. The Nurses' Health Study: lifestyle and health among women. Nat Rev Cancer 2005, 5:388-396. 10.1038/nrc1608, 15864280.
14. Lunn M, McNeil D. Applying Cox regression to competing risks. Biometrics 1995, 51:524-532. 10.2307/2532940, 7662841.
15. Huang Z, Hankinson SE, Colditz GA, Stampfer MJ, Hunter DJ, Manson JE, Hennekens CH, Rosner B, Speizer FE, Willett WC. Dual effects of weight and weight gain on breast cancer risk. JAMA 1997, 278:1407-1411. 10.1001/jama.278.17.1407, 9355998.
16. Collaborative Group on Hormonal Factors in Breast Cancer Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 1997, 350:1047-1059. 10.1016/S0140-6736(97)08233-0, 10213546, Collaborative Group on Hormonal Factors in Breast Cancer.
17. Morimoto LM, White E, Chen Z, Chlebowski RT, Hays J, Kuller L, Lopez AM, Manson J, Margolis KL, Muti PC, Stefanick ML, McTiernan A. Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States). Cancer Causes Control 2002, 13:741-751. 10.1023/A:1020239211145, 12420953.
18. Reeves GK, Pirie K, Green J, Bull D, Beral V. Reproductive factors and specific histological types of breast cancer: prospective study and meta-analysis. Br J Cancer 2009, 100:538-544. 10.1038/sj.bjc.6604853, 2658546, 19190634.
19. Li CI, Malone KE, Daling JR, Potter JD, Bernstein L, Marchbanks PA, Strom BL, Simon MS, Press MF, Ursin G, Burkman RT, Folger SG, Norman S, McDonald JA, Spirtas R. Timing of menarche and first full-term birth in relation to breast cancer risk. Am J Epidemiol 2008, 167:230-239. 10.1093/aje/kwm271, 17965112.
20. Phipps AI, Li CI, Kerlikowske K, Barlow WE, Buist DS. Risk factors for ductal, lobular, and mixed ductal-lobular breast cancer in a screening population. Cancer Epidemiol Biomarkers Prev 2010, 19:1643-1654. 10.1158/1055-9965.EPI-10-0188, 20501751.
21. Li CI, Malone KE, Porter PL, Weiss NS, Tang MT, Daling JR. Reproductive and anthropometric factors in relation to the risk of lobular and ductal breast carcinoma among women 65-79 years of age. Int J Cancer 2003, 107:647-651. 10.1002/ijc.11465, 14520705.
22. Wohlfahrt J, Mouridsen H, Andersen PK, Melbye M. Reproductive risk factors for breast cancer by receptor status, histology, laterality and location. Int J Cancer 1999, 81:49-55. 10.1002/(SICI)1097-0215(19990331)81:1<49::AID-IJC10>3.0.CO;2-7, 10077152.
23. Rosenberg LU, Magnusson C, Lindstrom E, Wedren S, Hall P, Dickman PW. Menopausal hormone therapy and other breast cancer risk factors in relation to the risk of different histological subtypes of breast cancer: a case-control study. Breast Cancer Res 2006, 8:R11. 10.1186/bcr1378, 1413980, 16507159.
24. Ursin G, Bernstein L, Lord SJ, Karim R, Deapen D, Press MF, Daling JR, Norman SA, Liff JM, Marchbanks PA, Folger SG, Simon MS, Strom BL, Burkman RT, Weiss LK, Spirtas R. Reproductive factors and subtypes of breast cancer defined by hormone receptor and histology. Br J Cancer 2005, 93:364-371. 10.1038/sj.bjc.6602712, 2361558, 16079783.
25. García-Closas M, Brinton LA, Lissowska J, Chatterjee N, Peplonska B, Anderson WF, Szeszenia-Dabrowska N, Bardin-Mikolajczak A, Zatonski W, Blair A, Kalaylioglu Z, Rymkiewicz G, Mazepa-Sikora D, Kordek R, Lukaszek S, Sherman ME. Established breast cancer risk factors by clinically important tumour characteristics. Br J Cancer 2006, 95:123-129. 2360503, 16755295.
26. Li CI, Daling JR, Malone KE, Bernstein L, Marchbanks PA, Liff JM, Strom BL, Simon MS, Press MF, McDonald JA, Ursin G, Burkman RT, Deapen D, Spirtas R. Relationship between established breast cancer risk factors and risk of seven different histologic types of invasive breast cancer. Cancer Epidemiol Biomarkers Prev 2006, 15:946-954. 10.1158/1055-9965.EPI-05-0881, 16702375.
27. Lee S, Kolonel L, Wilkens L, Wan P, Henderson B, Pike M. Postmenopausal hormone therapy and breast cancer risk: the Multiethnic Cohort. Int J Cancer 2006, 118:1285-1291. 10.1002/ijc.21481, 16170777.
28. Brinton LA, Richesson D, Leitzmann MF, Gierach GL, Schatzkin A, Mouw T, Hollenbeck AR, Lacey JV. Menopausal hormone therapy and breast cancer risk in the NIH-AARP Diet and Health Study Cohort. Cancer Epidemiol Biomarkers Prev 2008, 17:3150-3160. 10.1158/1055-9965.EPI-08-0435, 2755180, 18990757.
29. Reeves GK, Beral V, Green J, Gathani T, Bull D. Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis. Lancet Oncol 2006, 7:910-918. 10.1016/S1470-2045(06)70911-1, 17081916.
30. Riva C, Dainese E, Caprara G, Rocca PC, Massarelli G, Tot T, Capella C, Eusebi V. Immunohistochemical study of androgen receptors in breast carcinoma: evidence of their frequent expression in lobular carcinoma. Virchows Arch 2005, 447:695-700. 10.1007/s00428-005-0003-6, 16075292.
31. Li CI, Uribe DJ, Daling JR. Clinical characteristics of different histologic types of breast cancer. Br J Cancer 2005, 93:1046-1052. 10.1038/sj.bjc.6602787, 2361680, 16175185.
32. Eheman CR, Shaw KM, Ryerson AB, Miller JW, Ajani UA, White MC. The changing incidence of in situ and invasive ductal and lobular breast carcinomas: United States, 1999-2004. Cancer Epidemiol Biomarkers Prev 2009, 18:1763-1769. 10.1158/1055-9965.EPI-08-1082, 19454615.
33. Clarke CA, Glaser SL, Uratsu CS, Selby JV, Kushi LH, Herrinton LJ. Recent declines in hormone therapy utilization and breast cancer incidence: clinical and population-based evidence. J Clin Oncol 2006, 24:e49-e50. 10.1200/JCO.2006.08.6504, 17114650.
34. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J, . Writing Group for the Women's Health Initiative Investigators Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002, 288:321-333. 10.1001/jama.288.3.321, 12117397, Writing Group for the Women's Health Initiative Investigators.
35. Li CI, Malone KE, Porter PL, Lawton TJ, Voigt LF, Cushing-Haugen KL, Lin MG, Yuan X, Daling JR. Relationship between menopausal hormone therapy and risk of ductal, lobular, and ductal-lobular breast carcinomas. Cancer Epidemiol Biomarkers Prev 2008, 17:43-50. 10.1158/1055-9965.EPI-07-0558, 18199710.
36. Chen CL, Weiss NS, Newcomb P, Barlow W, White E. Hormone replacement therapy in relation to breast cancer. JAMA 2002, 287:734-741. 10.1001/jama.287.6.734, 11851540.
37. Li CI, Malone KE, Porter PL, Weiss NS, Tang MT, Cushing-Haugen KL, Daling JR. Relationship between long durations and different regimens of hormone therapy and risk of breast cancer. JAMA 2003, 289:3254-3263. 10.1001/jama.289.24.3254, 12824206.
38. Fournier A, Fabre A, Mesrine S, Boutron-Ruault MC, Berrino F, Clavel-Chapelon F. Use of different postmenopausal hormone therapies and risk of histology- and hormone receptor-defined invasive breast cancer. J Clin Oncol 2008, 26:1260-1268. 10.1200/JCO.2007.13.4338, 2346534, 18323549.
39. Colditz GA, Hankinson SE, Hunter DJ, Willett WC, Manson JE, Stampfer MJ, Hennekens C, Rosner B, Speizer FE. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 1995, 332:1589-1593. 10.1056/NEJM199506153322401, 7753136.
40. Bakken K, Fournier A, Lund E, Waaseth M, Dumeaux V, Clavel-Chapelon F, Fabre A, Hémon B, Rinaldi S, Chajes V, Slimani N, Allen NE, Reeves GK, Bingham S, Khaw KT, Olsen A, Tjønneland A, Rodriguez L, Sánchez MJ, Etxezarreta PA, Ardanaz E, Tormo MJ, Peeters PH, van Gils CH, Steffen A, Schulz M, Chang-Claude J, Kaaks R, Tumino R, Gallo V, et al. Menopausal hormone therapy and breast cancer risk: impact of different treatments. The European Prospective Investigation into Cancer and Nutrition. Int J Cancer 2011, 128:144-156. 10.1002/ijc.25314, 20232395.
41. Friedenreich CM. Review of anthropometric factors and breast cancer risk. Eur J Cancer Prev 2001, 10:15-32. 10.1097/00008469-200102000-00003, 11263588.
42. Colditz GA, Rosner BA, Chen WY, Holmes MD, Hankinson SE. Risk factors for breast cancer according to estrogen and progesterone receptor status. J Natl Cancer Inst 2004, 96:218-228. 10.1093/jnci/djh025, 14759989.
43. Li CI, Malone KE, Porter PL, Weiss NS, Tang MT, Daling JR. The relationship between alcohol use and risk of breast cancer by histology and hormone receptor status among women 65-79 years of age. Cancer Epidemiol Biomarkers Prev 2003, 12:1061-1066.
44. Clavel-Chapelon F. Cumulative number of menstrual cycles and breast cancer risk: results from the E3N cohort study of French women. Cancer Causes Control 2002, 13:831-838. 10.1023/A:1020684821837, 2001234, 12462548.
45. Russo J, Rivera R, Russo IH. Influence of age and parity on the development of the human breast. Breast Cancer Res Treat 1992, 23:211-218. 10.1007/BF01833517, 1463860.
46. Korkola JE, DeVries S, Fridlyand J, Hwang ES, Estep AL, Chen YY, Chew KL, Dairkee SH, Jensen RM, Waldman FM. Differentiation of lobular versus ductal breast carcinomas by expression microarray analysis. Cancer Res 2003, 63:7167-7175.
47. Zhao H, Langerød A, Ji Y, Nowels KW, Nesland JM, Tibshirani R, Bukholm IK, Kåresen R, Botstein D, Børresen-Dale AL, Jeffrey SS. Different gene expression patterns in invasive lobular and ductal carcinomas of the breast. Mol Biol Cell 2004, 15:2523-2536. 10.1091/mbc.E03-11-0786, 420079, 15034139.